Christine L. Chung
Overview
Christine L. Chung received an average of $4M in total compensation, including $470K in salary, at FibroGen from 2019 to 2021.
Source: SEC filings on April 28, 2022 and April 23, 2020.
Related executives
We found ten more executives who work or worked at FibroGen.
Enrique Conterno
FibroGen
Chief Executive Officer
Mark Eisner
FibroGen
Chief Medical Officer
Pat Cotroneo
FibroGen
Chief Financial Officer
Elias Kouchakji
FibroGen
Senior Vice President, Clinical Development, Drug Safety, and Pharmacovigilance
Thane Wettig
FibroGen
Chief Commercial Officer
Juan Graham
FibroGen
Chief Financial Officer
K Yu
FibroGen
Chief Medical Officer
James Schoeneck
FibroGen